Francis deSouza is chief executive of Illumina Inc. "Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grail -- Update" at 7:53 a.m. ET incorrectly said Mr. deSouza was CEO of Grail. (Sept. 21, 2020)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121 USD | -1.48% | +3.74% | -13.06% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.06% | 19.28B | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.57% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Illumina : Correction to Illumina Acquisition of Grail Article